FindTrial
Sign In

To study the levels of Vitamin K2-7 in healthy subjects

A prospective survey of plasma levels of vitamin K2-7 (MK-7) in healthy volunteers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/03/018278
Enrollment
50
Registered
2019-03-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Synergia Life Sciences Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male and female aged 28 to 45 healthy subjects. Having a Body Mass Index (BMI) between 18.5 and 24.9 (both inclusive), calculated as weight in kg / height in sq.m. Willing to give informed consent.

Exclusion criteria

Exclusion criteria: People who are suffering from any systemic illness. People who are on corticosteroids and oral contraceptives. People on antibiotics within last week People with seropositive status. Pregnancy and lactating women Participation in clinical trials evaluating investigational pharmaceuticals or biologics within 3 months or devices within 30 days of admission to the study. People who are on coumarin analogues or Quinine Hydrochloride. People who have history of smoking, history of alcohol. substance abuse, within last week.

Design outcomes

Primary

MeasureTime frame
The primary objective is to study the levels of Vitamin K2-7 in healthy volunteersTimepoint: 1 day—

Secondary

MeasureTime frame
Vitamin K2-7 levelsTimepoint: 1 day—

Countries

India

Contacts

Public ContactDr Shashank Jadhav

Synergia Life Sciences Pvt Ltd

yogesh_dound@yahoo.com022-24055607

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 14, 2026